• Sign In
  • Home
  • News
    • Politics
      • White House
      • Senate
      • House
      • Campaigns
  • Policy
  • 2026 Election
  • Opinion
    • Editorials
    • Op-Eds
  • In Focus
  • Restoring America
  • Magazine
  • Watch
  • Sponsored
    • Powering Progress
    • ASAE – Association Leadership
    • Examining Tax Reform
    • Fix TSCA
    • National Parks
    • Inside the Corn Belt
  • TWS Archive
Search
LogoWashington Examiner
Subscribe
LogoWashington Examiner
Sign in
Subscribe
  • News
    • Politics
      • Trump Administration
      • White House
      • Senate
      • House
      • Campaigns
    • Business
    • World
    • Investigations
    • Justice
    • Supreme Court
    • Crime
    • Entertainment
    • Washington Secrets
  • Policy
    • Defense
    • National Security
    • Energy and Environment
    • Education
    • Immigration
    • Finance and Economy
    • Healthcare
    • Foreign Policy
    • Tech
    • Infrastructure
    • Space
  • 2026 Election
  • Trump Administration
  • IN FOCUS
  • Commentary
    • Columnists
    • Editorials
    • Think Tanks
    • Beltway Confidential
    • Op-Eds
  • Restoring America
    • Patriotism and Unity
    • Faith, Freedom, and Self-Reliance
    • Courage, Strength, and Optimism
    • Equality, Not Elitism
    • Community and Family
    • Fairness and Justice
    • Mission
  • Watch
  • Magazine
    • Magazine
    • Quarterly Briefing
    • Archives
    • Games
  • Sponsored
    • Powering Progress
    • ASAE – Association Leadership
    • National Parks
    • Examining Tax Reform
    • Fix TSCA
    • Inside the Corn Belt
  • Newsletters
More
    Home Tags FDA

    Tag: FDA

    FILE - In this Thursday, Feb. 28, 2013 file photo, a Merck logo is placed on scientist's lab coat in West Point, Pa. The Food and Drug Administration on Thursday, Sept. 4, 2014 said it has granted accelerated approval to Merck's Keytruda, for treating melanoma that's spread or can't be surgically removed, in patients previously treated with another drug. (AP Photo/Matt Rourke, File)
    Business

    FDA OKs Merck drug, 1st in new cancer drug class

    Linda Johnson -
    September 4, 2014 9:41 pm
    0
    FDA: Little evidence to support testosterone drugs
    Business

    FDA: Little evidence to support testosterone drugs

    Matthew Perrone -
    September 3, 2014 7:18 pm
    0
    Drug companies seek dismissal of City of Chicago’s opioid lawsuit; claim issues fall within FDA’s jurisdiction

    Drug companies seek dismissal of City of Chicago’s opioid lawsuit; claim issues fall within FDA’s jurisdiction

    Bethany Krajelis -
    September 1, 2014 1:23 am
    0
    Feds seek comment on lower-risk tobacco bid
    Business

    Feds seek comment on lower-risk tobacco bid

    Michael Felberbaum -
    August 26, 2014 6:22 pm
    0
    FDA approves Biogen’s MS drug Plegridy
    Business

    FDA approves Biogen’s MS drug Plegridy

    Washington Examiner -
    August 15, 2014 11:27 pm
    0
    FDA clears Avastin for late-stage cervical cancer
    Business

    FDA clears Avastin for late-stage cervical cancer

    Washington Examiner -
    August 15, 2014 5:48 pm
    0
    A field worker empties a bucket of Vidalia onions into a waiting truck in Lyons, Ga., earlier this summer. (AP Photo/David Goldman)
    Op-Eds

    Manhattan Moment: A new layer of regulation would boost cost of onions but not safety

    Jared Meyer -
    August 14, 2014 9:00 pm
    0
    FDA approves new sleeping drug from Merck
    Business

    FDA approves new sleeping drug from Merck

    Matthew Perrone -
    August 13, 2014 8:39 pm
    0
    FDA approves lung preservation machine
    Business

    FDA approves lung preservation machine

    Washington Examiner -
    August 12, 2014 7:25 pm
    0
    FDA approves first DNA-based test for colon cancer
    Business

    FDA approves first DNA-based test for colon cancer

    Matthew Perrone -
    August 11, 2014 10:43 pm
    0
    1...165166167...180Page 166 of 180
    LogoWashington Examiner
    Do Not Sell or Share My Personal Information
    Facebook
    Twitter
    Youtube

    NEWS

    • Politics
      • White House
      • Senate
      • House
      • Campaigns
    • Business
    • World
    • Investigations
    • Justice
    • Supreme Court
    • Crime
    • Washington Secrets
    • Entertainment
    • Sports

    POLICY

    • Defense
    • National Security
    • Energy
    • Immigration
    • Finance and Economy
    • Healthcare
    • Foreign Policy
    • Tech
    • Infrastructure
    • Space

    COMMENTARY

    • Columnists
    • Editorials
    • Think Tanks
    • Beltway Confidential
    • Op-Eds

    RESTORING AMERICA

    • Patriotism and Unity
    • Faith, Freedom, and Self-Reliance
    • Courage, Strength, and Optimism
    • Equality, Not Elitism
    • Community and Family
    • Fairness and Justice
    • Mission
    • WATCH
    • IN FOCUS
    • NEWSLETTERS
    • MAGAZINE ARCHIVE
    • Policies and Standards
    • Terms Of Service
    • Subscription Terms of Use
    • Privacy Policy
    • Your Privacy Choices
    • Transparency In Coverage
    • Advertise
    • Subscribe
    • Contact
    • Careers
    • Staff
    • About Examiner
    • Facebook
    • Twitter
    • © Copyright 2026. Washington Examiner. All Rights Reserved.